|
CPSF7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72968322892575E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88249416055442E-12 |
| Normal-vs-Stage2 |
2.079000E-03 |
| Normal-vs-Stage3 |
2.163600E-04 |
| Normal-vs-Stage4 |
1.025640E-02 |
| Stage1-vs-Stage2 |
6.858800E-01 |
| Stage1-vs-Stage3 |
4.040200E-01 |
| Stage1-vs-Stage4 |
2.217600E-02 |
| Stage2-vs-Stage3 |
8.121600E-01 |
| Stage2-vs-Stage4 |
2.063600E-01 |
| Stage3-vs-Stage4 |
2.465600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.86649592950994E-11 |
| Normal-vs-AfricanAmerican |
1.036700E-03 |
| Normal-vs-Asian |
1.056000E-02 |
| Caucasian-vs-AfricanAmerican |
8.846000E-01 |
| Caucasian-vs-Asian |
3.096600E-01 |
| AfricanAmerican-vs-Asian |
3.398800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.90890000034894E-07 |
| Normal-vs-Female |
1.96953564568503E-13 |
| Male-vs-Female |
4.244900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.907400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.71059857787282E-11 |
| Normal-vs-Age(61-80Yrs) |
1.45340000035077E-07 |
| Normal-vs-Age(81-100Yrs) |
1.385680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.657900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.675580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.614200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.756400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.932200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.419400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.12339999997135E-06 |
| Normal-vs-Grade 2 |
2.06956674020375E-12 |
| Normal-vs-Grade 3 |
7.75289999976891E-07 |
| Normal-vs-Grade 4 |
3.994800E-01 |
| Grade 1-vs-Grade 2 |
8.199100E-03 |
| Grade 1-vs-Grade 3 |
2.983500E-03 |
| Grade 1-vs-Grade 4 |
3.01179999995238E-06 |
| Grade 2-vs-Grade 3 |
1.570110E-02 |
| Grade 2-vs-Grade 4 |
2.26410000003785E-06 |
| Grade 3-vs-Grade 4 |
1.133650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.321400E-01 |
| ccA subtype-vs-ccB subtype |
1.62525548574877E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80490000722955E-09 |
| Normal-vs-N1 |
9.191800E-01 |
| N0-vs-N1 |
3.842000E-03 |
|
|
